Clinical trial
A Phase 2 Open Label Trial of 3K3A-APC in Amyotrophic Lateral Sclerosis
NCT05039268 is registered in ClinicalTrials.gov with Macquarie University, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Open Label Trial of 3K3A-APC in Amyotrophic Lateral Sclerosis
- Lead sponsor
- Macquarie University, Australia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 25, 2021
- Completion date
- September 12, 2022
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.